University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 21 of 23
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
NCT00717275
Anterior Cruciate Ligament Reconstruction and Plyometric Exercise
NCT01851655
Study of Capecitabine to Treat Recurrent High Grade Gliomas
NCT00717197
Antimicrobial Susceptibility Patterns of N. Gonorrhea Isolates in an Era of Quinolone Resistance
NCT00692822
Rural Lifestyle Intervention Treatment Effectiveness Trial
NCT00912652
Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx
NCT00797290
Response to Albuterol Delivered Through an Anti-static Valved Holding Chamber During Nocturnal Bronchospasm
NCT01111110
Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
NCT00692783
Proton Therapy for Low and Intermediate Risk Prostate Cancer
NCT00693238
Neulasta in Type 1 Diabetes
NCT00662519
Adjunctive Neuromuscular Electrical Stimulation for the Rehabilitation of Swallowing
NCT01279824
Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure
NCT00669279
Proton Therapy for Unresectable Cancer (CA) of Pancreas
NCT00685763
Pharmacokinetics and Pharmacodynamics of Fructose
NCT00661947
Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay
NCT00643578
LXRA Gene Polymorphisms and Response to Fenofibrate
NCT00644592
Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?
NCT00735111
Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers
NCT00607347
Vitamin B6 Dependence of One-Carbon Metabolism
NCT00877812
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
NCT01006889
Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis
NCT00601068
Induction Related BK Viremia in Renal Transplant Patients
NCT00610961
Shoulder Rotational Flexibility and Throwing Arm Injuries of Baseball Pitchers
NCT00631826
Proton Radiation Therapy for Pituitary Adenoma
NCT00798057
Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
NCT00475332
Photon/Proton Radiation Therapy for Oropharyngeal Cancers
NCT00797446
Use of Fenofibrate for Primary Biliary Cirrhosis
NCT00575042
Training the Arm and Hand After Stroke Using Auditory Rhythm Cues
NCT00523523
COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI
NCT00523367
Evaluation of Pancreatobiliary Disorders in Patients With Altered Gastric Anatomy
NCT01238341
The Clinical Utility of Overtube Use at the Time of Endoscopy
NCT00861263
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
NCT00998335
Mechanisms of Neural Mobilization in the Treatment of Chronic Pain
NCT00929123
Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
NCT00887510
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease
NCT00955032
Treating Intention In Aphasia: Neuroplastic Substrates
NCT00567242
Prevention of Low Back Pain in the Military
NCT00373009
Restoring Walking in Non-ambulatory Children With Severe Chronic Spinal Cord Injury (SCI) (Kids STEP Study)
NCT00488280
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
NCT00432744
Proton Therapy for Chordomas and/or Chondrosarcomas
NCT00797602
Mechanisms and Treatment Response of Aggressive Periodontitis in Children
NCT01330719
The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders
NCT00861198
Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods
NCT01227382
Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor
NCT00954421
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
NCT00429052
Biological Effects of Weight Loss In Older, Obese Women
NCT01032733
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
NCT00375089
Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses
NCT00797498
Post Stroke Hand Functions: Bilateral Movements and Electrical Stimulation Treatments
NCT00369668
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
NCT00379808
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.